SUTRO BIOPHARMA, INC. Marketable Securities, Noncurrent
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2026-08-12
- 2026-06-30: Marketable Securities, Noncurrent $0.00.
- 2026-03-31: Marketable Securities, Noncurrent $0.00.
- 2025-12-31: Marketable Securities, Noncurrent $0.00.
- 2025-09-30: Marketable Securities, Noncurrent $0.00.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 |
| 2022-03-31 | $20.70M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $68.78M 10-K · filed 2023-03-30 |
| 2021-09-30 | $64.28M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $60.01M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $74.61M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.65M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.19M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $15.61M 10-K · filed 2021-03-18 |
| 2019-09-30 | $25.22M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $15.06M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $13.75M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |